Results demonstrate that the extract, at IC50 doses, was able to significantly decrease the expression of CD44, CD24, NANOG, SOX-2, and OCT-4, indicating a reduction in the amount of cancer stem cells (CSCs) in the culture (Figure 5). The gene discussed is CD44; the disease is cancer.